Work for Brainsway Ltd.?

Claim Your Profile

Brainsway Ltd. Logo Image

Brainsway Ltd.

Brainsway Ltd. Banner Image

About Brainsway Ltd.

51-200 Employees
Based in Jerusalem, Israel

BrainsWay is a commercial stage medical device company focused on the development and sale of non-invasive neurostimulation products using the Company’s proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology. The Company received marketing authorization from the U.S. Food and Drug Administration (FDA) for its products for a variety of patient populations, including in 2013 for patients with major depressive disorder (MDD), in 2018 for patients with obsessive-compulsive disorder (OCD), and in 2020 for patients with smoking addiction. BrainsWay is currently conducting clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders.

Ticker:
BWAY
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Diagnostic Substances (See More Diagnostic Substances Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol